NLP 1: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 129352 |
| SCHEMBL ID | 9291198 |
| SCHEMBL ID | 8405642 |
| MeSH ID | M0164706 |
| Synonym |
|---|
| nlp 1 |
| 2-nlp-3 |
| nlp-1 |
| 121064-77-5 |
| 5-(3-(2-nitro-1-imidazyl)propyl)phenanthridium |
| phenanthridinium, 5-(3-(2-nitro-1h-imidazol-1-yl)propyl)-, bromide |
| 5-(3-(2-nitro-1h-imidazol-1-yl)propyl)-phenanthridinium bromide |
| SCHEMBL9291198 |
| SCHEMBL8405642 |
| 5-[3-(2-nitro-1-imidazolyl)-propyl]-phen-anthridinium bromide |
| 5-[3-(2-nitro-1h-imidazol-1-yl)propyl]phenanthridin-5-ium bromide |
| DTXSID80923662 |
| 5-[3-(2-nitroimidazol-1-yl)propyl]phenanthridin-5-ium;bromide |
| AKOS040753294 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.63) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||